Blood Culture Tests Market Size & Share, Sector / Industry Report & Analysis 2025 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Blood Culture Tests Market


The global Blood Culture Tests market size is projected to reach US$ 7.43 billion by 2026, from US$ 4.4 billion in 2020, at a CAGR of 9.1% during 2021-2026. Growing approval rate of new products, such as instruments and consumables for Bloodstream Infections (BSI) diagnosis, by regulatory authorities is a major factor contributing to the growth.

Blood culture tests play a vital role in diagnosis of bacterial, fungal, and mycobacterial among other infections. Various techniques, including conventional/manual and automated blood culture methods, are used by healthcare professionals for the detection of infection. Thus, the demand is expected to rise in near future.

Rising prevalence of infectious diseases, BSIs, and sepsis is expected to be the main factor driving the market growth. According to the World Health Organization (WHO), about 250,000 cases of BSIs occur in the U.S. annually, and among them, around 80,000 patients in ICUs suffer from catheter-related BSIs. As a result, there is a high demand for advanced products by hospitals and clinical diagnostics laboratories for the detection of bacterial, fungal, and mycobacterial infections.

There has been an increase in R&D activities by many healthcare companies to develop advanced products such as instruments, consumables, and software. Investment on R&D for the development of novel product is a crucial strategy of vendors to support long-term growth of their businesses. For instance, Becton, Dickinson and Company, a leading blood culture testing product provider, invested around USD 1,430 million in R&D in 2016.
Stringent government regulations for the development and manufacturing of diagnostic products, including blood culture tests products, could hinder the market growth. The diagnostic products, such as instruments, kits, reagents, media, and assays, undergo rigorous clinical trials prior to a regulatory approval. This leads to a significant rise in the costs incurred by the manufacturers and delay in product launch. Commercialization of diagnostic products depends on successful completion of clinical trials, which is a long, uncertain, and costly process. In addition, product recall is another major challenge faced by manufacturers, which could adversely affect the growth.

Market Segmentation, Outlook & Viewpoint: Global Blood Culture Tests Market

Product Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

Consumables

  
Bacterial Infections
  
Fungal Infections
  
Mycobacterial Infections
  
Blood Culture Media
  
Aerobic
  
Anaerobic
  
Fungi/Yeast
  
Others
  
Assay, Kits, and Reagents
  
Blood Culture Accessories

Instruments

  
Bacterial Infections
  
Fungal Infections
  
Mycobacterial Infections
  
Laboratory Equipment
  
Incubators
  
Colony counters
  
Microscopes
  
Gram stainers
  
Automated Blood Culture Systems

Software & Services

  
Bacterial Infections
  
Fungal Infections
  
Mycobacterial Infections

Technique Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Conventional
  
Automated

Technology Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

Culture-based Technology

Molecular Technology

  
PCR
  
Microarray
  
PNA-FISH

Proteomic technology

Application Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Bacterial Infections
  
Fungal Infections
  
Mycobacterial Infections

End Use Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2026)

  
Hospital Laboratories
  
Reference Laboratories
  
Others

Key Players, Recent Developments & Regional Insights: Global Blood Culture Tests Market

In 2018, consumables was the largest revenue generating segment of the blood culture tests market, due to rising application of products, such as blood culture media, assay, kits, and reagents, and other accessories, for diagnostics applications. In addition, repetitive purchase of consumables is another major driver boosting the segment growth.
The instruments segment is expected to witness significant CAGR during the forecast period due to product advancements. The automated systems, incubators, colony counters, microscopes, and gram strainers are widely used by hospitals and other diagnostic laboratories.

Diagnostics companies are focused on developing advance products to cater to the needs of their customers. For instance, in July 2014, bioMerieux, a leading diagnostics company, announced the CE mark attainment by its product VIRTUO-an advanced system for continuous monitoring of blood culture for microbial detection.
The demand for advanced blood culture testing products is high due to increasing prevalence of BSI and infectious diseases. Advanced automated systems provide fast results, minimize contamination risk, and deliver highly reliable results.

Technique Insights

On the basis of technique, the market is bifurcated into conventional and automated. Conventional technique was the highest revenue-grossing segment in 2018 due to its extensive use by hospitals, independent clinical laboratories, and pathology laboratories.

The automated blood culture technique segment is expected to showcase the highest CAGR during the forecast period, due to the technological advancements, such as faster and precise results, and rising investments on R&D by manufacturers for new product development.

The companies are focused on launching advanced instruments and consumables to provide highly reliable and efficient tests to their customers. For instance, in June 2014, Becton, Dickinson and Company launched the BD BACTEC FX40 Blood Culture System along with the BD EpiCenter Microbiology Data Management System.
U.S., Germany, France, U.K., China, Japan, and India are expected to account for a high market share. Increasing prevalence of infectious diseases, presence of a large number of diagnostics companies, and availability of a well-developed healthcare infrastructure are some of the factors that are anticipated to contribute to the growth.

Technology Insights

Based on technology, the market is segmented into culture-based, molecular, and proteomic. In 2018, culture-based technology segment held the largest market share in terms of revenue. This is due to high usage of this technology by various laboratories such as hospital, reference, pathology, and physician office laboratories.
Molecular technology segment is expected to register the highest CAGR during the forecast period. Increasing investment on R&D by manufactures and increase in the incidence of infectious diseases has led to demand for rapid diagnostic techniques for detecting the presence of bacterial or fungal infection in blood.

Increasing demand for advanced diagnostic technologies, such as microarray, Polymerase Chain Reaction (PCR), and Peptide Nucleic AcidFluorescent In Situ Hybridization (PNA-FISH), is expected to propel the market growth. The PNA-FISH technology sub-segment is expected to register the highest CAGR during forecast period owing to its advantages, such as higher accuracy, reduced test time, and higher specificity in tests.

Developing healthcare infrastructure and rising disposable income in Asia Pacific and MEA region have spurred the demand for blood culture tests. In addition, increasing government initiatives to provide better quality healthcare facility coupled with easy availability advanced technologies is expected to boost the application of these tests.

Application Insights

Blood culture tests are used to detect bacterial infection that spreads into the blood in various conditions, such as osteomyelitis, meningitis, pneumonia, kidney infection, and sepsis. They can also detect fungal and mycobacterial infections. Bacterial infections segment held the leading market share in terms of revenue in 2018, as bacterial infection is the most common cause of BSI and other infections. The segment is also expected to register the highest CAGR during the forecast period.

Increasing healthcare awareness and improving healthcare infrastructure in developing countries, such as South Africa, Tanzania, China, India, and Argentina is expected to propel the segment growth. The governments of these countries are making efforts to provide better quality healthcare facilities and diagnostic products, which further supports the adoption.

The fungal infections segment is projected to witness lucrative growth over the study period owing to the prevalence of BSIs and rising number of sepsis cases worldwide. For instance, Candida species are predominant agents of fungal sepsis, which accounts for around 10% to 15% of healthcare-related infections.

End Use Insights

In 2018, hospital laboratories accounted for the largest market share in terms of revenue. This is owing to the increasing incidence of Hospital-acquired Infections (HAIs). According to the WHO, the rate of ICU-acquired infections, including Urinary Tract Infections (UTIs) and surgical-site wound infections, is around two to three times higher in developing countries as compared to developed countries. In Canada, about 8,000 patients die annually because of hospital-acquired infections.

In addition, the hospital laboratories segment is expected to expand at the fastest CAGR over the forecast period. Rising healthcare awareness along with initiatives by the government and nongovernment organizations to prevent and control infectious diseases is the main factor responsible for the growth. For instance, the Centers for Disease Control and Prevention (CDC) collaborated with the government of South Africa to develop national HIV clinical and research guidelines, support HIV and TB programs, and conduct epidemiology training.

The reference laboratories segment is projected to showcase lucrative growth over the forecast period owing to increase in outsourcing of blood culture tests by hospitals to reference laboratories. The reference laboratories are equipped with novel and advanced diagnostic techniques, which provide more accurate, reliable, and fast result.
The other end use segments are academic research laboratories, bacteriological laboratories, pathology laboratories, and physician office laboratories. This segment is also projected to grow at significant pace during the forecast period.

Regional Insights

North America held the leading market share in terms of revenue in 2018, due to the presence of many large healthcare companies such as Becton, Dickinson and Company; bioMerieux SA; Thermo Fisher Scientific, Inc.; and Roche Diagnostics.

Growth of Europe market is anticipated to be driven by availability of advanced diagnostics products and presence of highly developed healthcare infrastructure in the European countries like Germany, U.K., Switzerland, and France. Also, growing investments on R&D by manufactures for new product development are expected to propel the growth.

Asia Pacific is projected to witness the highest CAGR during the forecast period due to high prevalence of infectious diseases and developing healthcare infrastructure. Many diagnostic companies are targeting Asian countries, such as China and India, for business expansion. The presence of large base of target population and increasing disposable income in Asia Pacific are some of the key factors contributing to the regional market growth.

Blood Culture Tests Market Share Insights

Some of the key players operating in the market are Becton, Dickinson and Company; bioMerieux SA; Thermo Fisher Scientific, Inc.; Danaher Corporation; Luminex Corporation; Roche; BrU.K.er Corporation; and Abbott Laboratories. Major companies are undertaking various strategic initiatives including mergers and acquisitions, collaborations, new product development and launch, and regional expansions for serving the unmet customer needs.

The leading manufacturers such as Becton, Dickinson and Company; Roche Diagnostics, and Thermo Fisher Scientific, Inc. provide a broad range of advanced blood culture test products through their strong global distribution channel. It has led to intense competition amongst manufacturers, which is expected to affect the profit margin of vendors.

Mergers and acquisitions help the manufacturers expand their existing product portfolio along with geographical reach. For instance, in June 2016, Luminex Corporation completed the acquisition of Nanosphere, Inc. to strengthen their molecular microbiology and diagnostics businesses.

Key Insights Covered: Global Blood Culture Tests Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Blood Culture Tests industry.
2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Blood Culture Tests industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Blood Culture Tests industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Blood Culture Tests industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Blood Culture Tests industry.

Research Methodology: Global Blood Culture Tests Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other